
Things that are wrapped up are usually seen as positive, but that is certainly not the case for the cancer cells that receive the ‘gift’ of chemotherapy wrapped in Herceptine.
A recent study of 991 women affected by the highly aggressive HER2-positive cancer cells has examined the effectiveness of a treatment that combines chemotherapy with the antibody Herceptine, rather than using the two as individual treatments.
Allerede abonnent? Log ind.
Læs hele artiklen
Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app